Comment

  • 21 May 2017

    Pacific Biosciences: don’t count them out yet

    The first-quarter earnings release of Pacific Biosciences last month contained a mixed bag of information, and was swiftly followed by share prices plummeting by 24%. While investors balked at the...

Go Top